Notify me when P. Kent Hawryluk files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MBX | MBX Biosciences, Inc. | Common Stock, par value $0.0001 per share | 4.3% | $34,925,782 | 1,995,759 | P. Kent Hawryluk | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|